Stock Price Forecast

March 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Opko Health Inc chart...

About the Company

opko health is a diversified healthcare company that seeks to establish industry leading positions in large, rapidly growing markets. our diagnostics business includes bioreference laboratories, the nation's third largest clinical laboratory with a core genetic testing business and a 400 person sales and marketing team to drive growth and leverage new products, including the 4kscore® prostate cancer test and the claros® 1 in office immunoassay platform. our pharmaceutical business features rayaldee, an fda approved treatment for shpt in stage 3-­4 ckd patients with vitamin d insufficiency (launched in november 2016), varubitm for chemotherapy induced nausea and vomiting (oral formulation launched by partner tesaro and iv formulation pending fda approval), opk88004, a once or twice weekly oxyntomodulin for type 2 diabetes and obesity, in phase 2 clinical trials, among the new class of glp-­1 glucagon receptor dual agonists, and opk88003, a selective androgen receptor modulator for benig

CEO

Phillip Frost

Exchange

NASDAQ

Website

http://www.opko.com/

$2B

Total Revenue

339

Employees

$669M

Market Capitalization

-6.37

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $OPK News

Opko Health (OPK) Q4 2023 Earnings Call Transcript

20d ago, source:

Opko Health(NASDAQ: OPK) Q4 2023 Earnings Call Feb 27, 2024, 4:30 p.m. ET Good day, and welcome to the OPKO Health fourth quarter 2023 financial results conference call. [Operator instructions] Please ...

OPKO Health Inc (OPK) Reports Fourth Quarter 2023 Results

20d ago, source: Yahoo Finance

Warning! GuruFocus has detected 5 Warning Signs with OPK. On February 27, 2024, OPKO Health Inc (NASDAQ:OPK) released its 8-K ...

AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV

13d ago, source:

Study delivers first clinical safety and pharmacokinetic data as proof of concept for the use of multispecific antibodies in humans• Candidate ...

What Lies Ahead For Opko Health Inc (NASDAQ: OPK) In 2024?

5d ago, source:

Opko Health Inc (NASDAQ:OPK) shares, rose in value, with the stock price down by -0.93% to the previous day’s close as strong demand from buyers drove the stock to $0.92. Actively observing the price ...

2 Biotech Industry Vets to Lead AxoSim Board

12d ago, source: New

Dale Pfost and David WeinerNEW ORLEANS ─ Dale Pfost and David Weiner have been appointed co-chairs of AxoSim’s board of ...

Connected Drug Delivery Devices Market Surging Towards a Projected US$ 1.6 Billion Milestone by 2028

11d ago, source: Future Market Insights

At a compound annual growth rate (CAGR) of 23.6%, the global connected drug delivery devices market sale, estimated at US$ ...

Cancer Recurrence Monitoring Kit Market Set for Promising Growth, Predicted CAGR of 12.6% by 2030

1d ago, source: PharmiWeb

Public health initiatives and campaigns focused on cancer awareness can further drive market growth. The Cancer Recurrence Monitoring Kit Market faces challenges related to the lack of standardization ...

Beam Therapeutics: Strong Buy Rating on Impressive Q4 Earnings and Promising Pipeline Developments

19d ago, source:

Analyst Yanan Zhu of Wells Fargo maintained a Buy rating on Beam Therapeutics (BEAM – Research Report), with a price target of $75.00.

Reproductive Genetics Market Size To Grow By USD 17.2 Billion From 2024 to 2033 – Market.Us

13d ago, source: PharmiWeb

According to a recent report by Market.us, the Global Reproductive Genetics Market size is expected to be worth around USD 17.2 Billion by 2033 from USD 5.1 Billion in 2023, growing at a CAGR of 12.9% ...

Gastonia home health care company reach settlement for five-year Medicaid fraud allegations

6d ago, source: Yahoo

Family First Home Health Care Inc. — now known as Gaston Piedmont Health Care Inc. — and its owner Marion James were accused of knowingly violating the Federal and North Carolina False Claims Acts ...

Oregon health officials give emergency OK to Corvallis Clinic’s acquisition by insurance giant UnitedHealth Group

on MSN ago, source:

Oregon health officials gave an emergency approval to the acquisition of the medical practice The Corvallis Clinic by Optum, an affiliate of the insurance giant UnitedHealth Group, sidestepping a ...

‘Improved libido, hormonal balance’: Discover 6 health benefits of Okro water

2d ago, source: Nigerian Tribune on MSN

Do you know that the health benefits of okro is not just about preparing and eating it with a swallow? Okro is a fruit with its essentials; taking the water used in soaking it also has nutritional ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...